email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1246 - 1260
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Nhwa Starts China Trial of Novel IV Opioid Analgesic
$5.00
Available
dMed-Clinipace Raises $50 Million for China-US Clinical CRO Operations
$5.00
Available
Eucure Approved for US Phase II Trials of Combination Therapies
$5.00
Available
EpimAb Bio Starts Clinical Trials of Two Bispecific Candidates
$5.00
Available
Abbisko Out-Licenses Rights to Non-Oncology Indications for CSF-1R Inhibitor
$5.00
Available
SciClone Files China BLA for Neuroblastoma Treatment
$5.00
Available
Harbour BioMed Reports Positive Data from Myasthenia Gravis Trial
$5.00
Available
Sirnaomics Closes $105 Million Funding for RNAi Portfolio
$5.00
Available
Denovo Acquires Alzheimer's Disease Candidate from Lundbeck
$5.00
Available
Zentalis Closes $150 Million Secondary Offering for US-China Operations
$5.00
Available
I-Mab Starts Clinical Development of Two 4-1BB Bispecific Candidates
$5.00
Available
HutchMed Completes $537 Million Hong Kong IPO for Oncology Drugs
$5.00
Available
ArriVent Raises $150 Million to In-license China Drugs for Global Markets
$5.00
Available
Simcere Acquires China Rights to Alzheimer's Drug in $565 Million Deal
$5.00
Available
Eight Roads Launches its Fifth China Healthcare Fund with $400 Million
$5.00
Available